WTX101

ALXN1840 · Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WTX101, covering 2021-09-29 to 2021-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of WTX101 (ALXN1840) in Adult Wilson Disease Patients [Phase 2]